Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations-Reference-Cited by-同舟云学术

Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations

Published:2013-04 Issue:1-2 Volume:447 Page:38-46
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Serrano Dolores R.,Hernández Leticia,Fleire Laura,González-Alvarez Iban,Montoya Ana,Ballesteros María P.,Dea-Ayuela María A.,Miró Guadalupe,Bolás-Fernández Francisco,Torrado Juan J.

Funder

Spanish Ministry of Science and Innovation (MICINN)

Complutense University and Madrid Community Administration

Spanish Ministry of Education

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity;Adams;Biomacromolecules,2003

2. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length;Adams;J. Control. Release,2003

3. Liposomal amphotericin B:a unique pharmacokinetic profile. An unfinished story;Azanza;Rev. Esp. Quimioter,2012

4. Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs;Bekersky;Pharm. Res.,1999

5. Clinical pharmacokinetics of systemically administered antimycotics;Bellmann;Curr. Clin. Pharmacol.,2007

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distearoyl Phosphatidylglycerol and Dioleoyl Phosphatidylglycerol Increase the Retention and Reduce the Toxicity of Amphotericin B-Loaded in Nanoemulsions;Nanomedicine;2024-01-31

2. Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies;European Journal of Pharmaceutics and Biopharmaceutics;2023-05

3. Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996‐2020);Journal of Veterinary Internal Medicine;2023-05

4. Effect of Amphotericin B on the thermodynamic stability, aggregation state, hemolysis and antifungal activity of Amphotericin B-nonionic surfactant micellar system;Journal of Molecular Liquids;2023-04

5. Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers;International Journal of Pharmaceutics;2023-03